WAVE LIFE SCIENCES LTD. SG9999014716 08/06/2024 TO APPROVE, BY A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT SECTION 14A SAY-ON-PAY VOTES ISSUER 4500000 66251 FOR 4500000 FOR 2 DYNATRACE, INC. US2681501092 08/23/2024 NON-BINDING ADVISORY VOTE ON THE COMPENSATION OF DYNATRACE'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 109000 0 UNVOTED 0 FOR 2 WISE PLC GB00BL9YR756 09/18/2024 TO APPROVE THE DIRECTORS REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 277026 0 UNVOTED 0 FOR 2 WISE PLC GB00BL9YR756 09/18/2024 TO APPROVE THE DIRECTORS REMUNERATION POLICY SECTION 14A SAY-ON-PAY VOTES ISSUER 277026 0 UNVOTED 0 FOR 2 ELASTIC N.V. NL0013056914 10/01/2024 NON-BINDING ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DESCRIBED IN THE PROXY STATEMENT. SECTION 14A SAY-ON-PAY VOTES ISSUER 483 17017 UNVOTED 0 FOR 2 MICROSOFT CORPORATION US5949181045 12/10/2024 ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION ("SAY-ON-PAY VOTE"). SECTION 14A SAY-ON-PAY VOTES ISSUER 22000 0 ABSTAIN 22000 FOR 2 PALO ALTO NETWORKS, INC. US6974351057 12/10/2024 TO APPROVE, ON AN ADVISORY BASIS, THE FREQUENCY OF HOLDING FUTURE ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 113 4387 ABSTAIN 113 FOR 2 PALO ALTO NETWORKS, INC. US6974351057 12/10/2024 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 113 4387 ABSTAIN 113 FOR 2 INVENTIVA SA FR0013233012 12/11/2024 APPROVAL OF THE REMUNERATION POLICY FOR THE CHIEF EXECUTIVE OFFICER (APPLICABLE FROM THE DATE OF SEPARATION OF DUTIES) SECTION 14A SAY-ON-PAY VOTES ISSUER 1148310 0 FOR 1148310 FOR 2 INVENTIVA SA FR0013233012 12/11/2024 AUTHORISATION TO BE GRANTED TO THE BOARD OF DIRECTORS TO FREELY ALLOCATE SHARES TO EMPLOYEES AND/OR CERTAIN CORPORATE OFFICERS SECTION 14A SAY-ON-PAY VOTES ISSUER 1148310 0 FOR 1148310 FOR 2 INVENTIVA SA FR0013233012 12/11/2024 AMENDMENT TO THE REMUNERATION POLICY FOR THE COMPANY'S DIRECTORS SECTION 14A SAY-ON-PAY VOTES ISSUER 1148310 0 FOR 1148310 FOR 2 INVENTIVA SA FR0013233012 12/11/2024 AMENDMENT TO THE REMUNERATION POLICY FOR THE DEPUTY CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 1148310 0 FOR 1148310 FOR 2 EXACT THERAPEUTICS AS NO0010852213 12/17/2024 BOARD AUTHORISATION FOR SHARE CAPITAL INCREASES IN CONNECTION WITH THE COMPANY'S SHARE OPTIONS FOR EXECUTIVE MANAGEMENT AND IN CONNECTION WITH BOARD REMUNERATION SECTION 14A SAY-ON-PAY VOTES ISSUER 1255956 0 FOR 1255956 FOR 2 INFINEON TECHNOLOGIES AG DE0006231004 02/20/2025 APPROVAL OF THE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 125000 0 ABSTAIN 125000 FOR 2 PHARMING GROUP NV NL0010391025 03/04/2025 REMUNERATION EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER: APPROVAL FOR COMPONENTS OF THE REMUNERATION PACKAGE FOR MR. CHOURAQUI, AS EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 2100000 0 ABSTAIN 2100000 FOR 2 PHARMING GROUP NV NL0010391025 03/04/2025 REMUNERATION EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER: AUTHORIZATION OF THE BOARD OF DIRECTORS FOR A PERIOD OF EIGHTEEN (18) MONTHS SECTION 14A SAY-ON-PAY VOTES ISSUER 2100000 0 ABSTAIN 2100000 FOR 2 ARROWHEAD PHARMACEUTICALS, INC. US04280A1007 03/12/2025 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 2549219 0 FOR 2549219 FOR 2 ARROWHEAD PHARMACEUTICALS, INC. US04280A1007 03/12/2025 ADVISORY VOTE ON FREQUENCY OF EXECUTIVE COMPENSATION ADVISORY VOTES. SECTION 14A SAY-ON-PAY VOTES ISSUER 2549219 0 1 YEAR 2549219 FOR 2 GENMAB A/S DK0010272202 03/12/2025 ADVISORY VOTE ON THE COMPENSATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 12764 0 FOR 12764 FOR 2 GENMAB A/S DK0010272202 03/12/2025 PROPOSALS FROM THE BOARD OF DIRECTOR: ADOPTION OF AMENDMENTS TO REMUNERATION POLICY FOR THE BOARD OF DIRECTORS AND EXECUTIVE MANAGEMENT OF GENMAB A/S SECTION 14A SAY-ON-PAY VOTES ISSUER 12764 0 FOR 12764 FOR 2 QUALCOMM INCORPORATED US7475251036 03/18/2025 APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 5108 9892 ABSTAIN 5108 FOR 2 SK HYNIX INC KR7000660001 03/27/2025 APPROVAL OF LIMITS ON REMUNERATION FOR DIRECTOR SECTION 14A SAY-ON-PAY VOTES ISSUER 60000 0 ABSTAIN 60000 FOR 2 ZEALAND PHARMA A/S DK0060257814 03/27/2025 PROPOSAL FROM THE BOARD OF DIRECTORS TO APPROVE THE COMPANY'S REMUNERATION REPORT BY ADVISORY VOTE SECTION 14A SAY-ON-PAY VOTES ISSUER 453466 4000 FOR 453466 FOR 2 GUBRA A/S DK0062266474 04/03/2025 PRESENTATION OF AND ADVISORY VOTE ON THE REMUNERATION REPORT. THE VOTE ON THE REMUNERATION REPORT IS A NON-BINDING ADVISORY VOTE AND IS SUBJECT TO SECTION 139B OF THE DANISH COMPANIES ACT. THE REMUNERATION REPORT HAS BEEN PREPARED IN ACCORDANCE WITH THE REQUIREMENTS PRESCRIBED BY SECTION 139B OF THE DANISH COMPANIES ACT AND CONTAINS, INTER ALIA, AN OVERALL VIEW OF THE TOTAL REMUNERATION FOR 2024 OF EACH MEMBER OF THE BOARD OF DIRECTORS AND THE EXECUTIVE MANAGEMENT OF THE COMPANY. THE REMUNERATION REPORT IS AVAILABLE AT THE COMPANY'S WEBSITE: WWW.GUBRA.DK UNDER 'INVESTORS GOV-ERNANCE DOCUMENTS'. PRESENTATION OF AND ADVISORY VOTE ON THE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 46982 5000 FOR 46982 FOR 2 FERRARI N.V. NL0011585146 04/16/2025 REMUNERATION REPORT 2024 SECTION 14A SAY-ON-PAY VOTES ISSUER 1500 0 ABSTAIN 1500 FOR 2 FERRARI N.V. NL0011585146 04/16/2025 APPROVAL OF AWARDS TO THE EXECUTIVE DIRECTORS. PROPOSAL TO APPROVE THE PROPOSED AWARD OF (RIGHTS TO SUBSCRIBE FOR) COMMON SHARES IN THE CAPITAL OF THE COMPANY TO THE EXECUTIVE DIRECTORS IN ACCORDANCE WITH ARTICLE 14.6 OF THE COMPANY'S ARTICLES OF ASSOCIATION AND DUTCH LAW SECTION 14A SAY-ON-PAY VOTES ISSUER 1500 0 ABSTAIN 1500 FOR 2 ADOBE INC. US00724F1012 04/22/2025 APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 13298 0 ABSTAIN 13298 FOR 2 ADOBE INC. US00724F1012 04/22/2025 STOCKHOLDER PROPOSAL REGARDING VOTE ON GOLDEN PARACHUTES. SECTION 14A SAY-ON-PAY VOTES SECURITY HOLDER 13298 0 ABSTAIN 13298 AGAINST 2 ASML HOLDING NV NL0010273215 04/23/2025 APPROVE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 1220 14855 ABSTAIN 1220 FOR 2 BE SEMICONDUCTOR INDUSTRIES NV BESI NL0012866412 04/23/2025 APPROVE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 29024 0 ABSTAIN 29024 FOR 2 EATON CORPORATION PLC IE00B8KQN827 04/23/2025 APPROVING, ON AN ADVISORY BASIS, THE COMPANY'S EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 5000 0 UNVOTED 0 FOR 2 GALDERMA GROUP AG CH1335392721 04/23/2025 CONSULTATIVE VOTE ON THE COMPENSATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 10000 17500 UNVOTED 0 FOR 2 THE BOEING COMPANY US0970231058 04/24/2025 APPROVE, ON AN ADVISORY BASIS, NAMED EXECUTIVE OFFICER COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 12500 0 ABSTAIN 12500 FOR 2 BIOINVENT INTERNATIONAL AB SE0015244520 04/29/2025 RESOLUTION ON APPROVAL OF REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 1623336 0 FOR 1623336 FOR 2 GALAPAGOS NV BE0003818359 04/29/2025 ACKNOWLEDGEMENT AND APPROVAL OF THE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 46345 0 FOR 46345 FOR 2 OCCIDENTAL PETROLEUM CORPORATION US6745991058 05/02/2025 ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION SECTION 14A SAY-ON-PAY VOTES ISSUER 10000 0 ABSTAIN 10000 FOR 2 EGETIS THERAPEUTICS AB SE0003815604 05/06/2025 APPROVE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 13456395 0 FOR 13456395 FOR 2 INTEL CORPORATION US4581401001 05/06/2025 ADVISORY VOTE ON EXECUTIVE COMPENSATION (SAY-ON-PAY). SECTION 14A SAY-ON-PAY VOTES ISSUER 250 39750 ABSTAIN 250 FOR 2 VICORE PHARMA HOLDING AB SE0007577895 05/06/2025 APPROVE REMUNERATION POLICY AND OTHER TERMS OF EMPLOYMENT FOR GROUP MANAGEMENT AND BOARD MEMBERS SECTION 14A SAY-ON-PAY VOTES ISSUER 8763239 0 FOR 8763239 FOR 2 VICORE PHARMA HOLDING AB SE0007577895 05/06/2025 APPROVE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 8763239 0 FOR 8763239 FOR 2 VICORE PHARMA HOLDING AB SE0007577895 05/06/2025 APPROVE INCENTIVE PROGRAM LTIP 2025 FOR KEY EMPLOYEES SECTION 14A SAY-ON-PAY VOTES ISSUER 8763239 0 FOR 8763239 FOR 2 GENSIGHT BIOLOGICS SA FR0013183985 05/13/2025 APPROVAL OF THE PRINCIPLE OF COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER AND/OR ANY OTHER EXECUTIVE CORPORATE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 12549774 0 FOR 12549774 FOR 2 GENSIGHT BIOLOGICS SA FR0013183985 05/13/2025 APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL COMPONENTS OF THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND PAID DURING THE PAST FINANCIAL YEAR OR GRANTED IN RESPECT OF THE SAME FINANCIAL YEAR TO MRS LAURENCE RODRIGUEZ, CHIEF EXECUTIVE OFFICER. SECTION 14A SAY-ON-PAY VOTES ISSUER 12549774 0 FOR 12549774 FOR 2 GENSIGHT BIOLOGICS SA FR0013183985 05/13/2025 AUTHORIZATION TO BE GIVEN TO THE BOARD OF DIRECTORS TO GRANT STOCK OPTIONS TO EMPLOYEES AND/OR CERTAIN CORPORATE OFFICERS OF THE COMPANY OR RELATED COMPANIES OR ECONOMIC INTEREST GROUPINGS, WAIVER BY SHAREHOLDERS OF THEIR PRE-EMPTIVE SUBSCRIPTION RIGHTS SECTION 14A SAY-ON-PAY VOTES ISSUER 12549774 0 FOR 12549774 FOR 2 GENSIGHT BIOLOGICS SA FR0013183985 05/13/2025 AUTHORIZATION TO BE GRANTED TO THE BOARD OF DIRECTORS TO ALLOT EXISTING SHARES AND/OR SHARES TO BE ISSUED TO EMPLOYEES AND/OR CERTAIN CORPORATE OFFICERS OF THE COMPANY WAIVER BY SHAREHOLDERS OF THEIR PRE-EMPTIVE SUBSCRIPTION RIGHTS, CEILING, VESTING PERIODS, AND ANY LOCK-UP PERIOD SECTION 14A SAY-ON-PAY VOTES ISSUER 12549774 0 FOR 12549774 FOR 2 PROTHENA CORPORATION PLC IE00B91XRN20 05/13/2025 TO APPROVE, IN A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF THE EXECUTIVE OFFICERS NAMED IN THE COMPANY'S PROXY STATEMENT FOR THE ANNUAL GENERAL MEETING. SECTION 14A SAY-ON-PAY VOTES ISSUER 1119847 0 FOR 1119847 FOR 2 TENCENT HOLDINGS LTD KYG875721634 05/14/2025 TO AUTHORISE THE BOARD OF DIRECTORS TO FIX THE DIRECTORS REMUNERATION SECTION 14A SAY-ON-PAY VOTES ISSUER 65000 0 ABSTAIN 65000 FOR 2 VERA THERAPEUTICS, INC. US92337R1014 05/14/2025 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT. SECTION 14A SAY-ON-PAY VOTES ISSUER 655228 0 FOR 655228 FOR 2 VERA THERAPEUTICS, INC. US92337R1014 05/14/2025 TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF STOCKHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 655228 0 1 YEAR 655228 FOR 2 ADYEN N.V. NL0012969182 05/15/2025 ANNUAL REPORT; REMUNERATION REPORT; PROPOSAL TO ADOPT THE ANNUAL ACCOUNTS; DIVIDEND POLICY AND RESERVATION OF PROFITS: ADVISE ON THE REMUNERATION REPORT OVER THE FINANCIAL YEAR 2024 SECTION 14A SAY-ON-PAY VOTES ISSUER 5850 0 ABSTAIN 5850 FOR 2 CANTARGIA AB SE0006371126 05/15/2025 APPROVE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 9477033 0 FOR 9477033 FOR 2 CANTARGIA AB SE0006371126 05/15/2025 APPROVE SHARE BASED INCENTIVE SCHEME FOR SENIOR EXECUTIVES AND KEY EMPLOYEES SECTION 14A SAY-ON-PAY VOTES ISSUER 9477033 0 FOR 9477033 FOR 2 HEIDELBERG PHARMA AG DE000A11QVV0 05/15/2025 RESOLUTION ON THE APPROVAL OF THE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 445566 0 FOR 445566 FOR 2 TRANSGENE SA FR0005175080 05/15/2025 APPROVAL OF FIXED, VARIABLE, AND EXCEPTIONAL ITEMS COMPRISING THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND PAID OR AWARDED FOR FINANCIAL YEAR 2024 TO THE COMPANY'S CORPORATE OFFICERS (THE CHAIRMAN AND CEO, THE DEPUTY CEO AND THE DIRECTORS) SECTION 14A SAY-ON-PAY VOTES ISSUER 2918624 0 FOR 2918624 FOR 2 TRANSGENE SA FR0005175080 05/15/2025 APPROVAL OF FIXED, VARIABLE, AND EXCEPTIONAL ITEMS COMPRISING THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND PAID OR AWARDED FOR FINANCIAL YEAR 2024 TO MR. ALESSANDRO RIVA IN HIS CAPACITY AS CHAIRMAN AND CEO SECTION 14A SAY-ON-PAY VOTES ISSUER 2918624 0 FOR 2918624 FOR 2 TRANSGENE SA FR0005175080 05/15/2025 APPROVAL OF FIXED, VARIABLE, AND EXCEPTIONAL ITEMS COMPRISING THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND PAID OR AWARDED FOR FINANCIAL YEAR 2024 TO MR. CHRISTOPHE ANCEL IN HIS CAPACITY AS DEPUTY CEO OF TRANSGENE SECTION 14A SAY-ON-PAY VOTES ISSUER 2918624 0 FOR 2918624 FOR 2 TRANSGENE SA FR0005175080 05/15/2025 APPROVAL OF ITEMS CONCERNING THE COMPENSATION POLICY FOR CORPORATE OFFICERS IN FINANCIAL YEAR 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 2918624 0 FOR 2918624 FOR 2 TRANSGENE SA FR0005175080 05/15/2025 APPROVAL OF THE CRITERIA AND PRINCIPLES FOR DETERMINING, DISTRIBUTING, AND AWARDING FIXED, VARIABLE, AND EXCEPTIONAL ITEMS COMPRISING THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND THAT MAY BE AWARDED IN FINANCIAL YEAR 2025 TO THE CHAIRMAN AND CEO OF TRANSGENE SECTION 14A SAY-ON-PAY VOTES ISSUER 2918624 0 FOR 2918624 FOR 2 TRANSGENE SA FR0005175080 05/15/2025 APPROVAL OF THE CRITERIA AND PRINCIPLES FOR DETERMINING, DISTRIBUTING, AND AWARDING FIXED, VARIABLE, AND EXCEPTIONAL ITEMS COMPRISING THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND THAT MAY BE AWARDED IN FINANCIAL YEAR 2025 TO THE DEPUTY CEO SECTION 14A SAY-ON-PAY VOTES ISSUER 2918624 0 FOR 2918624 FOR 2 TRANSGENE SA FR0005175080 05/15/2025 APPROVAL OF THE CRITERIA AND PRINCIPLES FOR DETERMINING, DISTRIBUTING, AND AWARDING FIXED, VARIABLE, AND EXCEPTIONAL ITEMS COMPRISING THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND THAT MAY BE AWARDED IN FINANCIAL YEAR 2025 TO THE DIRECTORS SECTION 14A SAY-ON-PAY VOTES ISSUER 2918624 0 FOR 2918624 FOR 2 TRANSGENE SA FR0005175080 05/15/2025 AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS TO AWARD FREE SHARES TO COMPANY AND GROUP EXECUTIVES AND EMPLOYEES, WITH CANCELLATION OF SHAREHOLDERS PREFERENTIAL SUBSCRIPTION RIGHTS SECTION 14A SAY-ON-PAY VOTES ISSUER 2918624 0 FOR 2918624 FOR 2 AMAZON.COM, INC. US0231351067 05/21/2025 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION SECTION 14A SAY-ON-PAY VOTES ISSUER 47391 9109 ABSTAIN 47391 FOR 2 BEIGENE LTD US07725L1026 05/21/2025 THAT, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT, BE AND IS HEREBY APPROVED. SECTION 14A SAY-ON-PAY VOTES ISSUER 421814 0 FOR 421814 FOR 2 MERUS N.V. NL0011606264 05/21/2025 APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF MERUS N.V.'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 789698 0 FOR 789698 FOR 2 CINCLUS PHARMA HOLDING AB SE0020388577 05/22/2025 APPROVE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 710000 0 FOR 710000 FOR 2 DASSAULT SYSTEMES SE FR0014003TT8 05/22/2025 COMPENSATION POLICY FOR CORPORATE OFFICERS (MANDATAIRES SOCIAUX) SECTION 14A SAY-ON-PAY VOTES ISSUER 65000 0 ABSTAIN 65000 FOR 2 DASSAULT SYSTEMES SE FR0014003TT8 05/22/2025 COMPENSATION ELEMENTS PAID IN 2024 OR GRANTED FOR FISCAL YEAR 2024 TO MR. PASCAL DALOZ, CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 65000 0 ABSTAIN 65000 FOR 2 DASSAULT SYSTEMES SE FR0014003TT8 05/22/2025 APPROVAL OF THE INFORMATION CONTAINED IN THE CORPORATE GOVERNANCE REPORT AND RELATING TO THE COMPENSATION OF CORPORATE OFFICERS (MANDATAIRES SOCIAUX) (ARTICLE L. 22-10-9 OF THE FRENCH COMMERCIAL CODE) SECTION 14A SAY-ON-PAY VOTES ISSUER 65000 0 ABSTAIN 65000 FOR 2 DASSAULT SYSTEMES SE FR0014003TT8 05/22/2025 AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS TO GRANT COMPANY SHARES TO CORPORATE OFFICERS (MANDATAIRES SOCIAUX) AND EMPLOYEES OF THE COMPANY AND ITS AFFILIATED COMPANIES, ENTAILING AUTOMATICALLY THAT SHAREHOLDERS WAIVE THEIR PREFERENTIAL SUBSCRIPTION RIGHTS SECTION 14A SAY-ON-PAY VOTES ISSUER 65000 0 ABSTAIN 65000 FOR 2 DASSAULT SYSTEMES SE FR0014003TT8 05/22/2025 AUTHORIZATION GRANTED TO THE BOARD OF DIRECTORS TO GRANT SHARE SUBSCRIPTION AND PURCHASE OPTIONS TO CORPORATE OFFICERS AND EMPLOYEES OF THE COMPANY AND ITS AFFILIATED COMPANIES ENTAILING THAT SHAREHOLDERS WAIVE THEIR PREFERENTIAL SUBSCRIPTION RIGHTS SECTION 14A SAY-ON-PAY VOTES ISSUER 65000 0 ABSTAIN 65000 FOR 2 INNATE PHARMA SA FR0010331421 05/22/2025 APPROVAL OF THE COMPONENTS OF OVERALL COMPENSATION AND BENEFITS GRANTED FOR THE 2024 FISCAL YEAR TO THE CORPORATE OFFICERS SECTION 14A SAY-ON-PAY VOTES ISSUER 2778366 0 FOR 2778366 FOR 2 INNATE PHARMA SA FR0010331421 05/22/2025 APPROVAL OF THE GENERAL PRINCIPLES OF THE COMPENSATION POLICY OF THE CORPORATE OFFICERS FOR THE 2025 FISCAL YEAR SECTION 14A SAY-ON-PAY VOTES ISSUER 2778366 0 FOR 2778366 FOR 2 INNATE PHARMA SA FR0010331421 05/22/2025 APPROVAL OF THE COMPENSATION POLICY OF THE CHIEF EXECUTIVE OFFICERS FOR THE 2025 FISCAL YEAR SECTION 14A SAY-ON-PAY VOTES ISSUER 2778366 0 FOR 2778366 FOR 2 INNATE PHARMA SA FR0010331421 05/22/2025 APPROVAL OF THE GENERAL PRINCIPLES OF THE COMPENSATION POLICY FOR CORPORATE OFFICERS FOR THE 2025 FISCAL YEAR SECTION 14A SAY-ON-PAY VOTES ISSUER 2778366 0 FOR 2778366 FOR 2 INNATE PHARMA SA FR0010331421 05/22/2025 AUTHORIZATION FOR THE BOARD OF DIRECTORS TO GRANT EXISTING OR FUTURE FREE SHARES BASED ON PERFORMANCE CRITERIA TO SALARIED EXECUTIVES, SALARIED MEMBERS OF THE EXECUTIVE COMMITTEE, SALARIED SENIOR EXECUTIVES AND/OR CORPORATE OFFICERS OF THE COMPANY OR ITS SUBSIDIARIES SECTION 14A SAY-ON-PAY VOTES ISSUER 2778366 0 FOR 2778366 FOR 2 INNATE PHARMA SA FR0010331421 05/22/2025 AUTHORIZATION FOR THE BOARD OF DIRECTORS TO ALLOCATE FREE SHARES, EITHER EXISTING OR TO BE ISSUED FOR NEW EXECUTIVES (EMPLOYEES AND/OR CORPORATE OFFICERS) OF THE COMPANY OR ITS SUBSIDIARIES SECTION 14A SAY-ON-PAY VOTES ISSUER 2778366 0 FOR 2778366 FOR 2 INNATE PHARMA SA FR0010331421 05/22/2025 AUTHORIZATION FOR THE BOARD OF DIRECTORS TO ALLOCATE FREE SHARES, EITHER EXISTING OR TO BE ISSUED, TO SALARIED EXECUTIVES, SALARIED MEMBERS OF THE EXECUTIVE COMMITTEE AND/OR CORPORATE OFFICERS OF THE COMPANY OR ITS SUBSIDIARIES SECTION 14A SAY-ON-PAY VOTES ISSUER 2778366 0 FOR 2778366 FOR 2 INNATE PHARMA SA FR0010331421 05/22/2025 AUTHORIZATION FOR THE EXECUTIVE BOARD TO GRANT EXISTING OR FUTURE FREE SHARES BASED ON THE ACHIEVEMENT OF PERFORMANCE CRITERIA TO SALARIED EXECUTIVES, SALARIED EXECUTIVE COMMITTEE MEMBERS, SALARIED SENIOR EXECUTIVES AND/OR CORPORATE OFFICERS OF THE COMPANY OR ITS SUBSIDIARIES SECTION 14A SAY-ON-PAY VOTES ISSUER 2778366 0 FOR 2778366 FOR 2 INNATE PHARMA SA FR0010331421 05/22/2025 AUTHORIZATION FOR THE EXECUTIVE BOARD TO GRANT EXISTING OR NEW FREE SHARES TO EMPLOYEES OF THE COMPANY OR ITS SUBSIDIARIES, FOR NEW EXECUTIVES (EMPLOYEES AND/OR CORPORATE OFFICERS) OF THE COMPANY OR ITS SUBSIDIARIES SECTION 14A SAY-ON-PAY VOTES ISSUER 2778366 0 FOR 2778366 FOR 2 INNATE PHARMA SA FR0010331421 05/22/2025 AUTHORIZATION FOR THE BOARD OF DIRECTORS TO ALLOCATE FREE SHARES, EITHER EXISTING OR TO BE ISSUED, TO SALARIED EXECUTIVES, MEMBERS OF THE EXECUTIVE COMMITTEE AND/OR CORPORATE OFFICERS OF THE COMPANY OR ITS SUBSIDIARIES SECTION 14A SAY-ON-PAY VOTES ISSUER 2778366 0 FOR 2778366 FOR 2 INVENTIVA SA FR0013233012 05/22/2025 DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. FREDERIC CREN IN HIS CAPACITY AS CHAIRMAN AND CHIEF EXECUTIVE OFFICER UNTIL 13 DECEMBER 2024 AND AS CHIEF EXECUTIVE OFFICER FROM 13 DECEMBER 2024 IN RESPECT OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 SECTION 14A SAY-ON-PAY VOTES ISSUER 7407407 0 FOR 7407407 FOR 2 INVENTIVA SA FR0013233012 05/22/2025 DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. PIERRE BROQUA IN HIS CAPACITY AS DEPUTY CHIEF EXECUTIVE OFFICER FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 SECTION 14A SAY-ON-PAY VOTES ISSUER 7407407 0 FOR 7407407 FOR 2 INVENTIVA SA FR0013233012 05/22/2025 APPROVAL OF THE INFORMATION ON THE REMUNERATION OF CORPORATE OFFICERS CONTAINED IN THE CORPORATE GOVERNANCE REPORT AND REFERRED TO IN SECTION I OF ARTICLE L. 22-10-9 OF THE FRENCH COMMERCIAL CODE SECTION 14A SAY-ON-PAY VOTES ISSUER 7407407 0 FOR 7407407 FOR 2 INVENTIVA SA FR0013233012 05/22/2025 APPROVAL OF THE REMUNERATION POLICY FOR MR. FREDERIC CREN AS CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 7407407 0 FOR 7407407 FOR 2 INVENTIVA SA FR0013233012 05/22/2025 APPROVAL OF THE REMUNERATION POLICY FOR MR. PIERRE BROQUA AS DEPUTY CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 7407407 0 FOR 7407407 FOR 2 INVENTIVA SA FR0013233012 05/22/2025 APPROVAL OF THE REMUNERATION POLICY FOR THE COMPANY'S DIRECTORS SECTION 14A SAY-ON-PAY VOTES ISSUER 7407407 0 FOR 7407407 FOR 2 SCHOLAR ROCK HOLDING CORPORATION US80706P1030 05/22/2025 TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 7225000 2025005 FOR 7225000 FOR 2 SERVICENOW, INC. US81762P1021 05/22/2025 ADVISORY VOTE TO APPROVE SERVICENOW'S NAMED EXECUTIVE OFFICER COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 74 9052 ABSTAIN 74 FOR 2 EXOSENS FR001400Q9V2 05/23/2025 APPROVAL OF THE 2025 REMUNERATION POLICY FOR MR. JEROME CERISIER, MANAGING DIRECTOR SECTION 14A SAY-ON-PAY VOTES ISSUER 15435 0 ABSTAIN 15435 FOR 2 EXOSENS FR001400Q9V2 05/23/2025 APPROVAL OF FIXED, VARIABLE, AND EXCEPTIONAL COMPENSATION COMPONENTS PAID OR GRANTED IN 2024 TO MR. JEROME CERISIER SECTION 14A SAY-ON-PAY VOTES ISSUER 15435 0 ABSTAIN 15435 FOR 2 EXOSENS FR001400Q9V2 05/23/2025 AUTHORIZATION TO GRANT SHARES OF THE COMPANY IN FAVOUR OF CORPORATE OFFICERS AND EMPLOYEES OF THE COMPANY AND AFFILIATED COMPANIES, AUTOMATICALLY ENTAILING THE WAIVER BY SHAREHOLDERS OF THEIR PREFERENTIAL SUBSCRIPTION RIGHTS SECTION 14A SAY-ON-PAY VOTES ISSUER 15435 0 ABSTAIN 15435 FOR 2 EXOSENS FR001400Q9V2 05/23/2025 AUTHORIZATION TO GRANT ORDINARY SHARE SUBSCRIPTION OR PURCHASE OPTIONS TO CORPORATE OFFICERS AND EMPLOYEES OF THE COMPANY AND ITS AFFILIATES, AUTOMATICALLY ENTAILING THE WAIVER BY SHAREHOLDERS OF THEIR PREFERENTIAL SUBSCRIPTION RIGHTS SECTION 14A SAY-ON-PAY VOTES ISSUER 15435 0 ABSTAIN 15435 FOR 2 EXOSENS FR001400Q9V2 05/23/2025 AUTHORIZATION TO ISSUE ORDINARY SHARE SUBSCRIPTION WARRANTS TO CORPORATE OFFICERS AND EMPLOYEES OF THE COMPANY AND ITS AFFILIATES, AUTOMATICALLY ENTAILING THE WAIVER BY SHAREHOLDERS OF THEIR PREFERENTIAL SUBSCRIPTION RIGHTS SECTION 14A SAY-ON-PAY VOTES ISSUER 15435 0 ABSTAIN 15435 FOR 2 EXOSENS FR001400Q9V2 05/23/2025 APPROVAL OF THE 2025 REMUNERATION POLICY FOR DIRECTORS SECTION 14A SAY-ON-PAY VOTES ISSUER 15435 0 ABSTAIN 15435 FOR 2 AELIS FARMA FR0014007ZB4 05/27/2025 APPROVE COMPENSATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 173021 0 ABSTAIN 173021 FOR 2 AELIS FARMA FR0014007ZB4 05/27/2025 APPROVE COMPENSATION OF CEO SECTION 14A SAY-ON-PAY VOTES ISSUER 173021 0 ABSTAIN 173021 FOR 2 AELIS FARMA FR0014007ZB4 05/27/2025 APPROVE REMUNERATION POLICY OF CEO SECTION 14A SAY-ON-PAY VOTES ISSUER 173021 0 ABSTAIN 173021 FOR 2 AELIS FARMA FR0014007ZB4 05/27/2025 APPROVE REMUNERATION POLICY OF DIRECTORS SECTION 14A SAY-ON-PAY VOTES ISSUER 173021 0 ABSTAIN 173021 FOR 2 ARGENX SE NL0010832176 05/27/2025 THE 2024 REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 2045 8317 ABSTAIN 2045 FOR 2 ARGENX SE NL0010832176 05/27/2025 ADOPTION OF THE REMUNERATION POLICY SECTION 14A SAY-ON-PAY VOTES ISSUER 2045 8317 ABSTAIN 2045 FOR 2 CAMURUS AB SE0007692850 05/27/2025 APPROVE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 0 14000 UNVOTED 0 FOR 2 COUCHBASE, INC. US22207T1016 05/29/2025 APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 7 49843 UNVOTED 0 FOR 2 COUCHBASE, INC. US22207T1016 05/29/2025 APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE FREQUENCY OF FUTURE ADVISORY, NON-BINDING VOTES TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 7 49843 UNVOTED 0 FOR 2 SPYRE THERAPEUTICS INC. US00773J2024 05/29/2025 TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 314299 0 FOR 314299 FOR 2 WORKIVA INC. US98139A1051 05/29/2025 APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF WORKIVA'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 17500 0 ABSTAIN 17500 FOR 2 WORKIVA INC. US98139A1051 05/29/2025 INDICATION, ON AN ADVISORY BASIS, OF THE PREFERRED FREQUENCY OF STOCKHOLDER ADVISORY VOTES ON THE COMPENSATION OF WORKIVA'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 17500 0 ABSTAIN 17500 FOR 2 DYNE THERAPEUTICS, INC. US26818M1080 05/30/2025 TO VOTE, ON AN ADVISORY BASIS, TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2717987 0 FOR 2717987 FOR 2 DYNE THERAPEUTICS, INC. US26818M1080 05/30/2025 TO HOLD AN ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2717987 0 1 YEAR 2717987 FOR 2 LEXICON PHARMACEUTICALS, INC. US5288723027 06/02/2025 ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS SECTION 14A SAY-ON-PAY VOTES ISSUER 38918903 0 FOR 38918903 FOR 2 APELLIS PHARMACEUTICALS INC. US03753U1060 06/03/2025 TO HOLD AN ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2237511 0 FOR 2237511 FOR 2 APELLIS PHARMACEUTICALS INC. US03753U1060 06/03/2025 TO HOLD AN ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2237511 0 1 YEAR 2237511 FOR 2 DENALI THERAPEUTICS INC. US24823R1059 06/03/2025 ADVISORY VOTE ON EXECUTIVE COMPENSATION SECTION 14A SAY-ON-PAY VOTES ISSUER 728999 0 FOR 728999 FOR 2 STOKE THERAPEUTICS, INC. US86150R1077 06/03/2025 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 1932396 0 FOR 1932396 FOR 2 STOKE THERAPEUTICS, INC. US86150R1077 06/03/2025 TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF FUTURE STOCKHOLDER ADVISORY VOTES TO APPROVE THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 1932396 0 1 YEAR 1932396 FOR 2 GENERATION BIO CO. US37148K1007 06/04/2025 APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2818454 0 FOR 2818454 FOR 2 XENON PHARMACEUTICALS INC CA98420N1050 06/04/2025 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE CORPORATION'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 732761 0 FOR 732761 FOR 2 TABOOLA.COM LTD. IL0011754137 06/04/2025 TO APPROVE AN ADVISORY PROPOSAL ON EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 9969495 0 UNVOTED 9969495 FOR 1 TABOOLA.COM LTD. IL0011754137 06/04/2025 TO APPROVE AN AMENDMENT TO COMPENSATION TERMS FOR OUR CHIEF EXECUTIVE OFFICER (AND DIRECTOR). SECTION 14A SAY-ON-PAY VOTES ISSUER 9969495 0 UNVOTED 9969495 FOR 1 PAYPAL HOLDINGS, INC. US70450Y1038 06/05/2025 ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 3870 16130 ABSTAIN 3870 FOR 2 PROCORE TECHNOLOGIES, INC. US74275K1088 06/05/2025 TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 97 9903 UNVOTED 0 FOR 2 SALESFORCE, INC. US79466L3024 06/05/2025 APPROVAL, ON AN ADVISORY BASIS, OF THE FISCAL 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 15600 0 ABSTAIN 15600 FOR 2 SEMRUSH HOLDINGS, INC. US81686C1045 06/05/2025 NON-BINDING, ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 41257 83743 ABSTAIN 41257 FOR 2 SEMRUSH HOLDINGS, INC. US81686C1045 06/05/2025 NON-BINDING, ADVISORY VOTE ON THE FREQUENCY OF FUTURE NON-BINDING, ADVISORY VOTES TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 41257 83743 ABSTAIN 41257 FOR 2 TANGO THERAPEUTICS, INC. US87583X1090 06/05/2025 TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2245761 0 FOR 2245761 FOR 2 TANGO THERAPEUTICS, INC. US87583X1090 06/05/2025 NON-BINDING, ADVISORY VOTE ON THE FREQUENCY OF FUTURE NON-BINDING, ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2245761 0 1 YEAR 2245761 FOR 2 ABIVAX SA FR0012333284 06/06/2025 APPROVAL OF THE REMUNERATION ELEMENTS REFERRED TO IN SECTION I OF ARTICLE L. 22-10-9 OF THE FRENCH COMMERCIAL CODE, PURSUANT TO ARTICLE L. 22-10-34 OF THE FRENCH COMMERCIAL CODE SECTION 14A SAY-ON-PAY VOTES ISSUER 5403985 0 FOR 5403985 FOR 2 ABIVAX SA FR0012333284 06/06/2025 APPROVAL OF THE REMUNERATION ELEMENTS PAID DURING OR ALLOCATED IN RESPECT OF THE FINANCIAL YEAR 2024 TO MR. MARC DE GARIDEL IN HIS CAPACITY AS ACTING CHAIRMAN OF THE BOARD OF DIRECTORS AND CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 5403985 0 FOR 5403985 FOR 2 ABIVAX SA FR0012333284 06/06/2025 APPROVAL OF THE INFORMATION ON THE REMUNERATION OF CORPORATE OFFICERS CONTAINED IN THE CORPORATE GOVERNANCE REPORT AND REFERRED TO IN SECTION I OF ARTICLE L.22-10-9 OF THE FRENCH COMMERCIAL CODE SECTION 14A SAY-ON-PAY VOTES ISSUER 5403985 0 FOR 5403985 FOR 2 ABIVAX SA FR0012333284 06/06/2025 APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO THE CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 5403985 0 FOR 5403985 FOR 2 ABIVAX SA FR0012333284 06/06/2025 APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO DIRECTORS SECTION 14A SAY-ON-PAY VOTES ISSUER 5403985 0 FOR 5403985 FOR 2 BYD COMPANY LTD CNE100000296 06/06/2025 TO CONSIDER AND APPROVE THE PROPOSED FORMULATION OF THE RULES OF REMUNERATION MANAGEMENT OF DIRECTORS AND SENIOR MANAGEMENT BY THE COMPANY SECTION 14A SAY-ON-PAY VOTES ISSUER 109500 0 ABSTAIN 109500 FOR 2 REDDIT, INC. US75734B1008 06/09/2025 ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2780 18220 ABSTAIN 2780 FOR 2 REDDIT, INC. US75734B1008 06/09/2025 ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2780 18220 ABSTAIN 2780 FOR 2 ARCUS BIOSCIENCES, INC. US03969F1093 06/10/2025 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF ARCUS BIOSCIENCES' NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT. SECTION 14A SAY-ON-PAY VOTES ISSUER 1612077 0 UNVOTED 1612077 FOR 1 AVIDITY BIOSCIENCES, INC. US05370A1088 06/10/2025 TO CONSIDER AND VOTE UPON, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THIS PROXY STATEMENT PURSUANT TO THE COMPENSATION DISCLOSURE RULES OF THE SECURITIES AND EXCHANGE COMMISSION. SECTION 14A SAY-ON-PAY VOTES ISSUER 1110610 0 FOR 1110610 FOR 2 HORIZON ROBOTICS KYG4602S1057 06/10/2025 TO AUTHORIZE THE BOARD TO FIX THE RESPECTIVE DIRECTORS REMUNERATION SECTION 14A SAY-ON-PAY VOTES ISSUER 5602400 0 ABSTAIN 5602400 FOR 2 IRONWOOD PHARMACEUTICALS, INC. US46333X1081 06/10/2025 APPROVAL, BY NON-BINDING ADVISORY VOTE, OF THE COMPENSATION PAID TO THE NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 110532 0 FOR 110532 FOR 2 CRINETICS PHARMACEUTICALS INC. US22663K1079 06/11/2025 TO CONSIDER AND VOTE UPON, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT PURSUANT TO THE COMPENSATION DISCLOSURE RULES OF THE SECURITIES AND EXCHANGE COMMISSION. SECTION 14A SAY-ON-PAY VOTES ISSUER 1688611 0 FOR 1688611 FOR 2 DBV TECHNOLOGIES SA FR0010417345 06/11/2025 APPROVAL OF THE INFORMATION REFERRED TO IN ARTICLE L.22-10-9 I OF THE FRENCH COMMERCIAL CODE RELATING TO THE REMUNERATION OF CORPORATE OFFICERS FOR THE FINANCIAL YEAR 2024 SECTION 14A SAY-ON-PAY VOTES ISSUER 2319002 0 ABSTAIN 2319002 FOR 2 DBV TECHNOLOGIES SA FR0010417345 06/11/2025 APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID DURING THE FINANCIAL YEAR 2024 OR AWARDED FOR THE SAME FINANCIAL YEAR TO MR. DANIEL TASSE, CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 2319002 0 ABSTAIN 2319002 FOR 2 DBV TECHNOLOGIES SA FR0010417345 06/11/2025 CONSULTATIVE OPINION ON THE REMUNERATION OF EXECUTIVE MANAGERS 'NAMED EXECUTIVE OFFICERS' OTHER THAN THE CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 2319002 0 ABSTAIN 2319002 FOR 2 DBV TECHNOLOGIES SA FR0010417345 06/11/2025 APPROVAL OF THE REMUNERATION POLICY FOR DIRECTORS FOR THE FINANCIAL YEAR 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 2319002 0 ABSTAIN 2319002 FOR 2 DBV TECHNOLOGIES SA FR0010417345 06/11/2025 APPROVAL OF THE REMUNERATION POLICY FOR THE CHIEF EXECUTIVE OFFICER AND DEPUTY CHIEF EXECUTIVE OFFICERS FOR THE FINANCIAL YEAR 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 2319002 0 ABSTAIN 2319002 FOR 2 DBV TECHNOLOGIES SA FR0010417345 06/11/2025 AUTHORISATION TO BE GRANTED TO THE BOARD OF DIRECTORS TO ALLOCATE FREE SHARES TO EMPLOYEES AND/OR CERTAIN CORPORATE OFFICERS SECTION 14A SAY-ON-PAY VOTES ISSUER 2319002 0 ABSTAIN 2319002 FOR 2 DBV TECHNOLOGIES SA FR0010417345 06/11/2025 AUTHORISATION TO BE GRANTED TO THE BOARD OF DIRECTORS TO ALLOCATE OPTIONS TO SUBSCRIBE FOR AND/OR PURCHASE SHARES (STOCK OPTIONS) TO EMPLOYEES AND/OR CERTAIN CORPORATE OFFICERS OF THE COMPANY OR RELATED COMPANIES OR ECONOMIC INTEREST GROUPINGS SECTION 14A SAY-ON-PAY VOTES ISSUER 2319002 0 ABSTAIN 2319002 FOR 2 DBV TECHNOLOGIES SA FR0010417345 06/11/2025 INCREASE IN THE TOTAL REMUNERATION (ANNUAL PACKAGE) ALLOCATED TO DIRECTORS SECTION 14A SAY-ON-PAY VOTES ISSUER 2319002 0 ABSTAIN 2319002 FOR 2 DISC MEDICINE, INC. US2546041011 06/11/2025 TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 919992 0 FOR 919992 FOR 2 REMITLY GLOBAL, INC. US75960P1049 06/11/2025 TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 465449 0 UNVOTED 465449 FOR 1 REMITLY GLOBAL, INC. US75960P1049 06/11/2025 TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 18164 6836 ABSTAIN 18164 FOR 2 DISC MEDICINE, INC. US2546041011 06/11/2025 TO RECOMMEND, BY A NON-BINDING ADVISORY VOTE, THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 919992 0 1 YEAR 919992 FOR 2 KORRO BIO, INC. US5009461089 06/11/2025 NON-BINDING ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 277452 0 FOR 277452 FOR 2 KORRO BIO, INC. US5009461089 06/11/2025 NON-BINDING ADVISORY VOTE ON THE FREQUENCY OF FUTURE NON-BINDING ADVISORY VOTES TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS SECTION 14A SAY-ON-PAY VOTES ISSUER 277452 0 1 YEAR 277452 FOR 2 ONWARD MEDICAL N.V. NL0015000HT4 06/11/2025 IMPLEMENTATION OF THE COMPENSATION POLICY OVER THE FINANCIAL YEAR 2024 SECTION 14A SAY-ON-PAY VOTES ISSUER 688390 0 FOR 688390 FOR 2 PHARMING GROUP NV NL0010391025 06/11/2025 ANNUAL REPORT 2024: REMUNERATION REPORT FOR 2024 (ADVISORY VOTING ITEM) SECTION 14A SAY-ON-PAY VOTES ISSUER 0 2100000 UNVOTED 0 FOR 2 TREVI THERAPEUTICS INC US89532M1018 06/11/2025 APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2461987 0 FOR 2461987 FOR 2 TREVI THERAPEUTICS INC US89532M1018 06/11/2025 APPROVAL, ON AN ADVISORY BASIS, OF THE FREQUENCY OF FUTURE ADVISORY VOTES TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2461987 0 1 YEAR 2461987 FOR 2 CULLINAN THERAPEUTICS, INC. US2300311063 06/12/2025 PROPOSAL TO VOTE, ON AN ADVISORY BASIS, TO APPROVE OUR NAMED EXECUTIVE OFFICER COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 1044094 0 FOR 1044094 FOR 2 CULLINAN THERAPEUTICS, INC. US2300311063 06/12/2025 PROPOSAL TO VOTE, ON AN ADVISORY BASIS, ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON OUR NAMED EXECUTIVE OFFICER COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 1044094 0 1 YEAR 1044094 FOR 2 SOLID BIOSCIENCES INC. US83422E2046 06/12/2025 THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 6402653 0 FOR 6402653 FOR 2 VAXCYTE, INC. US92243G1085 06/12/2025 APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 259085 0 FOR 259085 FOR 2 CARTESIAN THERAPEUTICS, INC. US8162123025 06/13/2025 TO APPROVE, ON A NON-BINDING AND ADVISORY BASIS, A RESOLUTION APPROVING THE COMPENSATION OF CARTESIAN THERAPEUTICS, INC.'S NAMED EXECUTIVE OFFICERS, AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT UNDER "EXECUTIVE AND DIRECTOR COMPENSATION." SECTION 14A SAY-ON-PAY VOTES ISSUER 272110 0 FOR 272110 FOR 2 EDGEWISE THERAPEUTICS INC US28036F1057 06/13/2025 CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2705915 0 FOR 2705915 FOR 2 EDGEWISE THERAPEUTICS INC US28036F1057 06/13/2025 CONDUCT AN ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2705915 0 1 YEAR 2705915 FOR 2 EXACT THERAPEUTICS AS NO0010852213 06/13/2025 REMUNERATION FOR THE PERIOD TO THE ANNUAL GENERAL MEETING IN 2026 SECTION 14A SAY-ON-PAY VOTES ISSUER 1255956 0 UNVOTED 1255956 FOR 2 CYCLERION THERAPEUTICS, INC. US23255M2044 06/16/2025 TO CONDUCT A NON-BINDING ADVISORY VOTE TO APPROVE THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 106440 9715 FOR 106440 FOR 2 CYCLERION THERAPEUTICS, INC. US23255M2044 06/16/2025 TO CONDUCT AN ADVISORY (NON-BINDING) VOTE ON THE FREQUENCY OF THE VOTE TO APPROVE THE EXECUTIVE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 106440 9715 1 YEAR 106440 FOR 2 IONQ, INC. US46222L1089 06/17/2025 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS IDENTIFIED IN THE 2024 SUMMARY COMPENSATION TABLE IN THE "EXECUTIVE COMPENSATION" SECTION OF THE PROXY STATEMENT (THE "SAY-ON-PAY VOTE"). SECTION 14A SAY-ON-PAY VOTES ISSUER 170000 0 UNVOTED 170000 FOR 1 AGENUS INC. US00847G8042 06/17/2025 TO APPROVE, IN A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 500000 0 FOR 500000 FOR 2 APOGEE THERAPEUTICS, INC. US03770N1019 06/17/2025 VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES TO APPROVE OUR NAMED EXECUTIVE OFFICERS' COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 512598 0 1 YEAR 512598 FOR 2 BICYCLE THERAPEUTICS PLC US0887861088 06/17/2025 TO APPROVE, ON ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT. SECTION 14A SAY-ON-PAY VOTES ISSUER 1552106 0 FOR 1552106 FOR 2 BICYCLE THERAPEUTICS PLC US0887861088 06/17/2025 TO APPROVE OUR DIRECTORS' REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 (THE "DIRECTORS' REMUNERATION REPORT"), WHICH IS SET FORTH AS ANNEX A TO THE PROXY STATEMENT. SECTION 14A SAY-ON-PAY VOTES ISSUER 1552106 0 FOR 1552106 FOR 2 PEGASYSTEMS INC. US7055731035 06/17/2025 TO APPROVE, BY A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 514 15986 UNVOTED 0 FOR 2 BLUEPRINT MEDICINES CORPORATION US09627Y1091 06/18/2025 APPROVAL OF A NON-BINDING ADVISORY VOTE ON THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 623870 0 FOR 623870 FOR 2 INFORMATICA INC. US45674M1018 06/18/2025 ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 1298 48702 UNVOTED 0 FOR 2 ROCKET PHARMACEUTICALS, INC. US77313F1066 06/18/2025 CONSIDER AND ACT UPON A NON-BINDING, ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 591263 0 FOR 591263 FOR 2 FERRARI GROUP PLC GB00BN0VZ646 06/19/2025 TO APPROVE THE DIRECTORS REMUNERATION POLICY SECTION 14A SAY-ON-PAY VOTES ISSUER 100000 0 ABSTAIN 100000 FOR 2 CENTESSA PHARMACEUTICALS PLC US1523091007 06/20/2025 TO RECEIVE AND APPROVE, ON AN ADVISORY BASIS, THE COMPANY'S U.K. STATUTORY DIRECTORS' REMUNERATION REPORT FOR THE FINANCIAL YEAR ENDED DECEMBER 31, 2024 (OTHER THAN THE DIRECTOR'S REMUNERATION POLICY WHICH IS SET ON PAGES A-3 TO A-25 OF THE DIRECTOR'S REMUNERATION REPORT), WHICH IS SET FORTH AS ANNEX A TO THE ATTACHED PROXY STATEMENT. SECTION 14A SAY-ON-PAY VOTES ISSUER 2600652 0 FOR 2600652 FOR 2 CENTESSA PHARMACEUTICALS PLC US1523091007 06/20/2025 TO RECEIVE AND APPROVE THE DIRECTORS' REMUNERATION POLICY AS SET OUT ON PAGES A-3 TO A-25 OF THE COMPANY'S UK STATUTORY DIRECTORS' REMUNERATION REPORT FOR THE FINANCIAL YEAR ENDED DECEMBER 31, 2024, WHICH IS SET FORTH AS ANNEX A TO THE ATTACHED PROXY STATEMENT, WHICH WILL TAKE EFFECT IMMEDIATELY AFTER THE END OF THE AGM. SECTION 14A SAY-ON-PAY VOTES ISSUER 2600652 0 FOR 2600652 FOR 2 GITLAB INC. US37637K1088 06/20/2025 APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION PAID BY GITLAB INC. TO ITS NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 25000 0 ABSTAIN 25000 FOR 2 MAAT PHARMA FR0012634822 06/20/2025 APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO THE MANAGING DIRECTOR SECTION 14A SAY-ON-PAY VOTES ISSUER 951501 0 FOR 951501 FOR 2 MAAT PHARMA FR0012634822 06/20/2025 APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO THE DIRECTORS SECTION 14A SAY-ON-PAY VOTES ISSUER 951501 0 FOR 951501 FOR 2 RHYTHM PHARMACEUTICALS, INC. US76243J1051 06/24/2025 APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS OF THE COMPANY. SECTION 14A SAY-ON-PAY VOTES ISSUER 238841 0 FOR 238841 FOR 2 VIVORYON THERAPEUTICS N.V. NL00150002Q7 06/24/2025 APPROVE REMUNERATION REPORT SECTION 14A SAY-ON-PAY VOTES ISSUER 118063 0 FOR 118063 FOR 2 VIVORYON THERAPEUTICS N.V. NL00150002Q7 06/24/2025 APPROVE REMUNERATION OF NON-EXECUTIVE DIRECTORS SECTION 14A SAY-ON-PAY VOTES ISSUER 118063 0 FOR 118063 FOR 2 KYMERA THERAPEUTICS, INC. US5015751044 06/25/2025 TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2829980 0 FOR 2829980 FOR 2 NVIDIA CORPORATION US67066G1040 06/25/2025 ADVISORY APPROVAL OF OUR EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 69485 0 ABSTAIN 69485 FOR 2 OSE IMMUNOTHERAPEUTICS SA FR0012127173 06/25/2025 APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO THE MANAGING DIRECTOR SECTION 14A SAY-ON-PAY VOTES ISSUER 354858 0 UNVOTED 0 FOR 2 OSE IMMUNOTHERAPEUTICS SA FR0012127173 06/25/2025 APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO DIRECTORS SECTION 14A SAY-ON-PAY VOTES ISSUER 354858 0 UNVOTED 0 FOR 2 OSE IMMUNOTHERAPEUTICS SA FR0012127173 06/25/2025 APPROVAL OF THE INFORMATION CONCERNING THE REMUNERATION OF CORPORATE OFFICERS FOR THE YEAR ENDED 31 DECEMBER 2024, MENTIONED IN I OF ARTICLE L. 22-10-9 OF THE FRENCH COMMERCIAL CODE SECTION 14A SAY-ON-PAY VOTES ISSUER 354858 0 UNVOTED 0 FOR 2 VALNEVA SE FR0004056851 06/25/2025 APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO MR. THOMAS LINGELBACH, CHIEF EXECUTIVE OFFICER, FOR THE FINANCIAL YEAR 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 1654267 44914 FOR 1654267 FOR 2 VALNEVA SE FR0004056851 06/25/2025 APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO MR. FRANCK GRIMAUD, DEPUTY CHIEF EXECUTIVE OFFICER, FOR THE FINANCIAL YEAR 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 1654267 44914 FOR 1654267 FOR 2 VALNEVA SE FR0004056851 06/25/2025 APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO MR. JUAN CARLOS JARAMILLO, DEPUTY CHIEF EXECUTIVE OFFICER, FOR THE FINANCIAL YEAR 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 1654267 44914 FOR 1654267 FOR 2 VALNEVA SE FR0004056851 06/25/2025 APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO MR. PETER BUHLER, DEPUTY CHIEF EXECUTIVE OFFICER, FOR THE FINANCIAL YEAR 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 1654267 44914 FOR 1654267 FOR 2 VALNEVA SE FR0004056851 06/25/2025 APPROVAL OF THE REMUNERATION POLICY APPLICABLE TO MRS. DIPAL PATEL, DEPUTY CHIEF EXECUTIVE OFFICER, FOR THE FINANCIAL YEAR 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 1654267 44914 FOR 1654267 FOR 2 VALNEVA SE FR0004056851 06/25/2025 APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND PAID DURING THE FINANCIAL YEAR ENDED 31 DECEMBER 2024, OR AWARDED IN RESPECT OF THE SAME FINANCIAL YEAR TO MR. THOMAS LINGELBACH, CHIEF EXECUTIVE OFFICE SECTION 14A SAY-ON-PAY VOTES ISSUER 1654267 44914 FOR 1654267 FOR 2 VALNEVA SE FR0004056851 06/25/2025 APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND PAID DURING THE FINANCIAL YEAR ENDED 31 DECEMBER 2024, OR AWARDED IN RESPECT OF THE SAME FINANCIAL YEAR TO MR. FRANCK GRIMAUD, DEPUTY CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 1654267 44914 FOR 1654267 FOR 2 VALNEVA SE FR0004056851 06/25/2025 APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND PAID DURING THE FINANCIAL YEAR ENDED 31 DECEMBER 2024, OR AWARDED IN RESPECT OF THE SAME FINANCIAL YEAR TO MR. JUAN CARLOS JARAMILLO, DEPUTY CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 1654267 44914 FOR 1654267 FOR 2 VALNEVA SE FR0004056851 06/25/2025 APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND PAID DURING THE FINANCIAL YEAR ENDED 31 DECEMBER 2024, OR AWARDED IN RESPECT OF THE SAME FINANCIAL YEAR TO MR. PETER BUHLER, DEPUTY CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 1654267 44914 FOR 1654267 FOR 2 VALNEVA SE FR0004056851 06/25/2025 APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND PAID DURING THE FINANCIAL YEAR ENDED 31 DECEMBER 2024, OR AWARDED IN RESPECT OF THE SAME FINANCIAL YEAR TO MRS. DIPAL PATEL, DEPUTY CHIEF EXECUTIVE OFFICER SECTION 14A SAY-ON-PAY VOTES ISSUER 1654267 44914 FOR 1654267 FOR 2 REVOLUTION MEDICINES, INC. US76155X1000 06/26/2025 TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT PURSUANT TO THE COMPENSATION DISCLOSURE RULES OF THE SECURITIES AND EXCHANGE COMMISSION ("SAY-ON-PAY"). SECTION 14A SAY-ON-PAY VOTES ISSUER 491743 0 FOR 491743 FOR 2 SILENCE THERAPEUTICS PLC US82686Q1013 06/26/2025 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT. SECTION 14A SAY-ON-PAY VOTES ISSUER 2442757 0 FOR 2442757 FOR 2 SILENCE THERAPEUTICS PLC US82686Q1013 06/26/2025 TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 2442757 0 1 YEAR 2442757 FOR 2 SILENCE THERAPEUTICS PLC US82686Q1013 06/26/2025 TO APPROVE OUR DIRECTORS' REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31, 2024, WHICH IS SET FORTH AS ANNEX A TO THE PROXY STATEMENT AND ON PAGES 32 TO 56 (INCLUSIVE) OF THE 2024 U.K. ANNUAL REPORT. SECTION 14A SAY-ON-PAY VOTES ISSUER 2442757 0 FOR 2442757 FOR 2 KE HOLDINGS INC US4824971042 06/27/2025 AS AN ORDINARY RESOLUTION, TO AUTHORIZE THE BOARD TO FIX THE REMUNERATION OF THE DIRECTORS. SECTION 14A SAY-ON-PAY VOTES ISSUER 105000 0 ABSTAIN 105000 FOR 2